We read with interest the paper by Dr J H Campbell and colleagues (December 1993;48:1248-51) investigating the value of bronchoscopy and bronchoalveolar lavage in patients receiving immunosuppressive therapy during bone marrow transplantation.
We have recently conducted a similar retrospective study of patients referred to us for bronchoscopy from our renal unit over a 30 month period. Out of a total of 40 referrals 16 patients were identified as receiving immunosuppressive therapy either for their renal disease or for a transplant. A diagnosis was made in eight of these: cytomegalovirus pneumonitis (3), pneumocystis pneumonia (2) , candida pneumonitis (1), invasive aspergillosis (1), and bacterial pneumonia (2 AUTHORS' REPLY We are grateful to Dr Girling and his colleagues for their comments on our report. We agree with their conclusion that at present it is wise to conclude that there is uncertainty about the exact role of surgery in the management of small cell carcinoma of the lung. No doubt surgeons will continue to operate on small peripheral nodules, only to find on pathological examination that a small cell carcinoma was resected. In our study seven such patients were included.
Whether patients with a known preoperative diagnosis of stage I or II small cell carcinoma should be operated upon is therefore the issue of concern. As pointed out by Girling et al, with intensive chemoradiotherapy programmes increasingly promising long term survival rates are reported which are in the same range as the median and long term survival reported in our study. The intention of such programmes is to deliver maximum cytotoxic therapy to the primary site, therefore enhancing local control without compromising the chemotherapy dose intensity needed for systemic control. For two reasons surgery (with adjuvant chemotherapy) may be preferred to chemoradiotherapy. Firstly, the reported local failure rate observed in such programmes may be as high as 28%' while with surgery this figure may be as low as 8%. Also, only patients with good performance status are able to tolerate intensive chemoradiotherapy programmes making surgery a good altemative for the average elderly patient with small cell lung cancer.
Again we agree with Girling and colleagues that a randomised trial comparing initial resection (as opposed to adjuvant surgery as in the trial by Lad et 
